Distribution of heparinase covalently immobilized to agarose: Experimental and theoretical studies
- 5 August 1987
- journal article
- research article
- Published by Wiley in Biotechnology & Bioengineering
- Vol. 30 (2), 196-207
- https://doi.org/10.1002/bit.260300209
Abstract
An immobilized enzyme reactor has been developed to remove heparin, the anticoagulant that is required in all extracorporeal devices for patients undergoing open‐heart surgery or kidney dialysis. The device uses the enzyme heparinase (EC 4.2.2.7), which is covalently linked to agarose with cyanogen bromide. A critical parameter in the development of a model for the degradation of heparin catalyzed by immobilized heparinase is the radial concentration profile of the enzyme within the agarose matrix. Experimental determinations of bound enzyme con centrations have been conducted previously for several enzyme systems using radioactive or fluorescent labels. For the development of the heparinase reactor it is necessary to use catalytically but not electrophoretically pure enzyme, and thus it is not possible to use the labeling techniques. To obtain information about the bound enzyme distribution, an experimental study of the intrinsic binding kinetics of heparinase to cyanogen bromide‐activated agarose was conducted. The binding reaction was studied as a function of both the concentration of heparinase and the gel‐reactive group. At conditions of functional group excess, the binding kinetics were pseudo first order in heparinase concentration with a rate constant equal to 0.12 Ccn (h−1), where Ccn is the gel‐reactive group concentration. The reactive group concentration remained constant within the 2–4‐h experiments. Competitive binding between heparinase and the protein contaminants was unimportant. A model was formulated for the immobilization procedure based on the diffusion of heparinase within the porous network and the binding kinetics as determined above. The model predicted the immobilization of heparinase to be kinetically controlled and the enzyme to distribute uniformly within the agarose matrix. These experimental techniques could be applied to predict the immobilized enzyme distribution for different enzyme systems that are not electrophoretically pure.This publication has 35 references indexed in Scilit:
- Enzymatic Removal of Bilirubin From Blood: A Potential Treatment for Neonatal JaundiceScience, 1985
- Immobilization of enzymes in porous supports: Effects of support-enzyme solution contactingBiotechnology & Bioengineering, 1984
- An Enzymatic System for Removing Heparin in Extracorporeal TherapyScience, 1982
- Procedures for the analysis of cyanogen bromide-activated Sepharose or Sephadex by quantitative determination of cyanate esters and imidocarbonatesAnalytical Biochemistry, 1981
- On shape normalization for non-uniformly active catalyst pelletsChemical Engineering Science, 1980
- Immobilized Enzymes for Medical ApplicationPublished by Springer Nature ,1980
- Studies of the Distribution of Proteins Bound to CNBr‐Activated Sepharose 6B at the Electron‐Microscopic LevelEuropean Journal of Biochemistry, 1975
- Binding of proteins to CNBr‐activated sepharose 4BFEBS Letters, 1974
- Covalent binding of molecules to CNBr-activated agarose: Parameters relevant to the activation and coupling reactionsBiochimica et Biophysica Acta (BBA) - General Subjects, 1974
- Method of Visualization of Matrix-Bound Proteins. Leucine Aminopeptidase Bound to Sepharose and Sephadex BeadsEuropean Journal of Biochemistry, 1972